U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07018076) titled 'Candidate Clinical Correlate of Prognostic Outcome for TB Study' on June 04.
Brief Summary: As part of the ongoing efforts within the Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) study, the Candidate Clinical Correlate as Prognostic Outcome for TB (C3PO) study serves as a supplement aimed at evaluating predictors and novel biomarkers of recurrent TB among TB survivors. Current tools for predicting TB recurrence risk are suboptimal, limiting the ability to assess new TB treatment regimens effectively. Identifying accurate sputum- or blood-based biomarkers for recurrence risk could significantly improve t...